Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma: a systematic review and economic evaluation

Health Technology Assessment

Type:

Extended Research Article Our publication formats
Authors:

Knight C, Hind D, Brewer N, Abbott V.
Journal:

Health Technology Assessment
Issue:

Volume: 8, Issue: 37
Published:

September 2004
Citation:

Knight C, Hind D, Brewer N, Abbott V. Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma: a systematic review and economic evaluation. Health Technol Assess 2004;8(37). https://doi.org/10.3310/hta8370
DOI:

https://doi.org/10.3310/hta8370